Though Medicare could stand to vastly increase access for a wider proportion of people, not every Medicare member will qualify.
Wegovy, pharmaceutical company Novo Nordisk's brand name for the drug semaglutide, was approved by the Food and Drug Administration in 2021. It assists in weight loss by reducing appetite with a hormone in the gut, and according to a recent study, it also decreases cardiovascular risk by around 20 percent.
Collection
[
|
...
]